The results showed that the knockdown of VASN in U118 cells led to increased activation of Jurkat cells (Figure 12B), whereas the overexpression of sVASN in U87 cells resulted in attenuated activation of Jurkat cells (Figure 12C), indicating the immunosuppressive effects of sVASN within the tumor microenvironment. The gene discussed is VASN; the disease is neoplasm.